DENVER The American Association for Cancer Research will host its Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development from Sept. 27-30, 2010, at the Sheraton Denver Downtown in Denver, Colo.
Recent advances in genomics, proteomics, molecular imaging and other new technologies are leading to a molecularly based reclassification of cancer. These approaches allow for a more precise understanding of a patient's tumor and a more personalized, targeted approach to therapy.
"This emerging understanding, together with the enhanced ability to characterize tumors from individual patients, creates many opportunities for improved treatment of malignancy and accelerated development of new therapeutics," said Program Chairperson Gordon B. Mills, M.D., Ph.D., chair of the department of systems biology at the University of Texas MD Anderson Cancer Center.
Mills will host a press conference on some of the new diagnostic methods under development on Sept. 28, at 1:00 p.m. MT.
The following are press releases, which are based on research that will be highlighted during the press conference:
Reporters who cannot attend the press conference in person can call in using the following information:
The AACR Communication Department is also highlighting the following research, which will be presented at the meeting:
|Contact: Jeremy Moore|
American Association for Cancer Research